Cite
MLA Citation
Christopher Geven et al.. “Safety, tolerability and pharmacokinetics/pharmacodynamics of the adrenomedullin antibody adrecizumab in a first‐in‐human study and during experimental human endotoxaemia in healthy subjects.” British journal of clinical pharmacology, vol. 84, 2018, pp. 2129–2141. http://access.bl.uk/ark:/81055/vdc_100068689491.0x000044